Literature DB >> 24059449

Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.

Laetitia P L Pelascini1, Ignazio Maggio, Jin Liu, Maarten Holkers, Toni Cathomen, Manuel A F V Gonçalves.   

Abstract

Zinc-finger nucleases (ZFNs) work as dimers to induce double-stranded DNA breaks (DSBs) at predefined chromosomal positions. In doing so, they constitute powerful triggers to edit and to interrogate the function of genomic sequences in higher eukaryotes. A preferred route to introduce ZFNs into somatic cells relies on their cotransduction with two integrase-defective lentiviral vectors (IDLVs) each encoding a monomer of a functional heterodimeric pair. The episomal nature of IDLVs diminishes the risk of genotoxicity and ensures the strict transient expression profile necessary to minimize deleterious effects associated with long-term ZFN activity. However, by deploying IDLVs and conventional lentiviral vectors encoding HPRT1- or eGFP-specific ZFNs, we report that DSB formation at target alleles is limited after IDLV-mediated ZFN transfer. This IDLV-specific underperformance stems, to a great extent, from the activity of chromatin-remodeling histone deacetylases (HDACs). Importantly, the prototypic and U.S. Food and Drug Administration-approved inhibitors of metal-dependent HDACs, trichostatin A and vorinostat, respectively, did not hinder illegitimate recombination-mediated repair of targeted chromosomal DSBs. This allowed rescuing IDLV-mediated site-directed mutagenesis to levels approaching those achieved by using their isogenic chromosomally integrating counterparts. Hence, HDAC inhibition constitutes an efficacious expedient to incorporate in genome-editing strategies based on transient IDLV-mediated ZFN expression. Finally, we compared two of the most commonly used readout systems to measure targeted gene knockout activities based on restriction and mismatch-sensitive endonucleases. These experiments indicate that these enzymatic assays display a similar performance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24059449      PMCID: PMC3869538          DOI: 10.1089/hgtb.2013.107

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  52 in total

1.  Surrogate reporters for enrichment of cells with nuclease-induced mutations.

Authors:  Hyojin Kim; Eunji Um; Sung-Rae Cho; Chorong Jung; Hyongbum Kim; Jin-Soo Kim
Journal:  Nat Methods       Date:  2011-10-09       Impact factor: 28.547

2.  Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo.

Authors:  Efren Riu; Zhi-Ying Chen; Hui Xu; Chen-Yi He; Mark A Kay
Journal:  Mol Ther       Date:  2007-04-24       Impact factor: 11.454

Review 3.  Integration-deficient lentiviral vectors: a slow coming of age.

Authors:  Klaus Wanisch; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2009-06-02       Impact factor: 11.454

Review 4.  Histone deacetylase inhibitors in lymphoma.

Authors:  Amanda Copeland; Daniela Buglio; Anas Younes
Journal:  Curr Opin Oncol       Date:  2010-09       Impact factor: 3.645

Review 5.  HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis.

Authors:  Jelena Vojinovic; Nemanja Damjanov
Journal:  Mol Med       Date:  2011-02-04       Impact factor: 6.354

6.  Cellular and molecular barriers to gene transfer by a cationic lipid.

Authors:  J Zabner; A J Fasbender; T Moninger; K A Poellinger; M J Welsh
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

7.  Rapid and sensitive lentivirus vector-based conditional gene expression assay to monitor and quantify cell fusion activity.

Authors:  Manuel A F V Gonçalves; Josephine M Janssen; Maarten Holkers; Antoine A F de Vries
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

8.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

9.  Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.

Authors:  R van Rensburg; I Beyer; X-Y Yao; H Wang; O Denisenko; Z-Y Li; D W Russell; D G Miller; P Gregory; M Holmes; K Bomsztyk; A Lieber
Journal:  Gene Ther       Date:  2012-03-22       Impact factor: 5.250

10.  Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.

Authors:  Brian Moldt; Nicklas H Staunstrup; Maria Jakobsen; Rafael J Yáñez-Muñoz; Jacob G Mikkelsen
Journal:  BMC Biotechnol       Date:  2008-08-09       Impact factor: 2.563

View more
  9 in total

1.  Adenoviral vector DNA for accurate genome editing with engineered nucleases.

Authors:  Maarten Holkers; Ignazio Maggio; Sara F D Henriques; Josephine M Janssen; Toni Cathomen; Manuel A F V Gonçalves
Journal:  Nat Methods       Date:  2014-08-24       Impact factor: 28.547

2.  Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors.

Authors:  Alok V Joglekar; Libby Stein; Michelle Ho; Megan D Hoban; Roger P Hollis; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2014-04-02       Impact factor: 5.695

3.  Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation.

Authors:  Kamola Saydaminova; Xun Ye; Hongjie Wang; Maximilian Richter; Martin Ho; HongZhuan Chen; Ning Xu; Jin-Soo Kim; Eirini Papapetrou; Michael C Holmes; Philip D Gregory; Donna Palmer; Philip Ng; Anja Ehrhardt; André Lieber
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-14       Impact factor: 6.698

4.  A high excision potential of TALENs for integrated DNA of HIV-based lentiviral vector.

Authors:  Hirotaka Ebina; Yuka Kanemura; Naoko Misawa; Tetsushi Sakuma; Tomoko Kobayashi; Takashi Yamamoto; Yoshio Koyanagi
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Two lymphoid cell lines potently silence unintegrated HIV-1 DNAs.

Authors:  Franziska K Geis; Demetra P Kelenis; Stephen P Goff
Journal:  Retrovirology       Date:  2022-07-09       Impact factor: 3.768

6.  Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells.

Authors:  Ignazio Maggio; Maarten Holkers; Jin Liu; Josephine M Janssen; Xiaoyu Chen; Manuel A F V Gonçalves
Journal:  Sci Rep       Date:  2014-05-29       Impact factor: 4.379

Review 7.  Engineered Viruses as Genome Editing Devices.

Authors:  Xiaoyu Chen; Manuel A F V Gonçalves
Journal:  Mol Ther       Date:  2015-09-04       Impact factor: 11.454

Review 8.  Adenoviral Vectors Meet Gene Editing: A Rising Partnership for the Genomic Engineering of Human Stem Cells and Their Progeny.

Authors:  Francesca Tasca; Qian Wang; Manuel A F V Gonçalves
Journal:  Cells       Date:  2020-04-13       Impact factor: 6.600

9.  The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes.

Authors:  Sabina Sánchez-Hernández; Alejandra Gutierrez-Guerrero; Rocío Martín-Guerra; Marina Cortijo-Gutierrez; María Tristán-Manzano; Sandra Rodriguez-Perales; Laura Sanchez; Jose Luis Garcia-Perez; Jesus Chato-Astrain; Ricardo Fernandez-Valades; Ana Belén Carrillo-Galvez; Per Anderson; Rosa Montes; Pedro J Real; Francisco Martin; Karim Benabdellah
Journal:  Mol Ther Nucleic Acids       Date:  2018-08-18       Impact factor: 8.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.